Wenwen Wei

1.6k citations
51 papers · 1.1k indexed · 1 hit paper · h-index 15
Topics
Acute Myeloid Leukemia Research (9 papers)CAR-T cell therapy research (8 papers)Immune Cell Function and Interaction (7 papers)

In The Last Decade

Wenwen Wei

50 papers receiving 1.1k citations

Hit Papers

NKG2D-CAR T cells eliminate senescent cells in aged mice ...20232026202420252023255075100

Peers

Wenwen Wei
Comparison fields: 5 of 95
  • Molecular Biology 505
  • Plant Science 334
  • Cancer Research 144
  • Oncology 143
  • Immunology 137
Replace Niaz Mahmood with:
Niaz Mahmood Canada
Jing Cheng China
Sivaprakasam Balasubramanian United States
Samir Devalaraja United States
Guido Leoni Italy
Arvind Pandey India
Manal Eid Egypt
Sung‐Jin Bae South Korea
Andrés Delgado Cañedo Brazil
Wenwen Wei relative to Niaz Mahmood Canada Niaz Mahmood's profile →
Citations per field
00.5×
Niaz Mahmood · 1×
Citations per year

Countries citing papers authored by Wenwen Wei

Since Specialization
Citations

This map shows the geographic impact of Wenwen Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenwen Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenwen Wei more than expected).

Fields of papers citing papers by Wenwen Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenwen Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenwen Wei. The network helps show where Wenwen Wei may publish in the future.

Co-authorship network of co-authors of Wenwen Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Wenwen Wei. A scholar is included among the top collaborators of Wenwen Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenwen Wei. Wenwen Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 2
4 7
5 14
6 10
7 0
8
NKG2D-CAR T cells eliminate senescent cells in aged mice and nonhuman primatesbreakdown →
114
9 6
10 7
11 4
12 20
13 8
14 18
15 4
16 10
17 10
18 12
19 10
20 21

About Wenwen Wei

Wenwen Wei is a scholar working on Hematology, Immunology and Cancer Research, having authored 51 papers that have together received 1.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (9 papers), CAR-T cell therapy research (8 papers) and Immune Cell Function and Interaction (7 papers). The work is most often cited by research in Biochemistry (130 citations), Cancer Research (144 citations) and Plant Science (334 citations). Wenwen Wei has collaborated with scholars based in China, United States and New Zealand. Frequent co-authors include Bo Zhang, Kunsong Chen, Jiyuan Shen, Wanpeng Xi, Ian Ferguson, Changjie Xu, Xudong Zhao, Dong Yang, Bin Sun and Xin Wang. Their work appears in journals such as Journal of Clinical Investigation, Blood and Journal of Agricultural and Food Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026